Skip to content
★ Sign in to follow
VH

Victoria Hull

Board Director
Insider activity · 24 months2 buys1 saleCumulative net flow
Total declarations
3
Company
1
▲ Purchases (2 ops.)
€286k
▼ Sales (1 ops.)
€58k

Latest filing published 28 Apr 2026 for Hikma Pharmaceuticals PLC, €230k.

Filing timeline

BuySale
Victoria Hull

Insider track record

Disclosed buys
2
Disclosed sells
1
Signal history

Closed purchases

Market purchases
2
Positive at T+90
50%
Median T+90
+7.6%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Victoria Hull: trading record in brief

Victoria Hull appears in our data through filings on Hikma Pharmaceuticals PLC shares, published by RNS (LSE). Over a trading history stretching from 8 April 2025 to 27 April 2026, the count stands at 3 filings.

On the open market, the record shows 2 purchases worth €286k and 1 sale worth €58k. Purchases outweigh sales by €228k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 1 purchase and no sales on the market.

The record was last updated on 28 April 2026 with an open-market purchase (€230k) in Hikma Pharmaceuticals PLC. Publication is fast: at least half of the trades appear on RNS (LSE) on the same day. Under the UK Market Abuse Regulation, managers have three business days to notify their trades. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Victoria Hull

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▲
    Non-Executive ChairExecutivesHikma Pharmaceuticals PLC
    198,829 GBP14RNS
    14,455 shares@ £13.7666.7% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:7e577389-dfc6-4254-b481-e9f10701b63b
    Canonical exit: 26 Jul 2026 (T+90)
  • ▲
    Senior Independent DirectorExecutivesHikma Pharmaceuticals PLC
    49,721 GBP21RNS
    3,214 shares@ £15.4716.4% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5e5506bf-dd0d-490e-af93-009bdcb91748-1
    Canonical exit: 5 Feb 2026 (T+90)
  • ▼
    Non-Executive DirectorExecutivesHikma Pharmaceuticals PLC
    49,986 GBP9RNS
    2,777 shares@ £18.0016.9% of flowLondon Stock Exchange (XLON)ISIN GB00B0LCW083RNS:5609164

3 of 3 declarations